<DOC>
	<DOCNO>NCT00634205</DOCNO>
	<brief_summary>The purpose study determine response rate combination doxorubicin valproate acid patient MM fail least one previous chemotherapy regimen include platinum derivative .</brief_summary>
	<brief_title>Phase II Study Valproate Doxorubicin Malignant Mesothelioma</brief_title>
	<detailed_description />
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Histological diagnosis malignant mesothelioma Unresectable inoperable malignant mesothelioma fail least one prior chemotherapy regimen include platinum derivative ( cisplatin carboplatin ) At least one evaluable measurable CTlesion Availability participate detailed followup protocol Signed informed consent Patients candidate surgery curative intent Patient previously treat anthracyclin derivative Performance status &lt; 60 Karnofsky scale A history prior malignant tumour , except nonmelanoma skin cancer situ carcinoma cervix cure malignant tumour ( 5year disease free interval ) A history prior HIV infection Polynuclear cell &lt; 2,000/mm³ Platelet cell &lt; 100,000/mm³ Abnormal coagulation test ( aPTT , PTT , prothrombin time ) and/or decrease fibrinogen Serum bilirubin &gt; 1.5 mg/100 ml Transaminases twice normal range Serum creatinine &gt; 1.5 mg/100 ml Recent myocardial infarction ( le 3 month prior date diagnosis ) Congestive cardiac failure ( ejectional fraction leave ventricle &lt; 50 % ) uncontrolled cardiac arrhythmia Uncontrolled infectious disease Active epilepsy need specific treatment Concomitant treatment IMAO , carbamazepine , mefloquine , phenobarbital , primidone , phenytoïn , lamotrigine , zidovudine Pregnancy refusal use active contraception A known allergy valproate acid and/or doxorubicin Serious medical psychological factor may prevent adherence treatment schedule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Mesothelioma</keyword>
	<keyword>Valproate</keyword>
	<keyword>Doxorubicin</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Phase II</keyword>
</DOC>